National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)s

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

111 Protocols (54 Active Accrual of new subjects, 57 Follow-up of previously enrolled subjects)

 06-CH-0090:

Evaluation of Whether the Selective Progesterone Receptor Modulator CDB-2914 Can Shrink Leiomyomata

 05-CH-0037:

The Effects of Hydrocortisone, Melatonin, and Placebo on Symptoms of Jet Lag

 05-CH-0013:

Adrenal Function in Critical Illness

 03-DK-0257:

Phase II Trial of Effect of Metreleptin Therapy in Severe Insulin Resistance

 03-DK-0256:

Inhibition of Intestinal Glucose Absorption by the Bioflavonoid Quercetin in the Obese and in Obese Type 2 Diabetics

 OH99-DK-N019:

The Food Intake Phenotype: Assessing Eating Behavior and Food Preferences as Risk Factors for Obesity

 OH82-DK-0136:

Cross-Sectional and Longitudinal Studies of 'Pre-Diabetes'

 94-DK-0133:

Genetic Markers for Focal Segmental Glomerulosclerosis

 94-DK-0127:

Pathogenesis of Glomerulosclerosis

 92-DK-0033:

Pharmacokinetics and Biodistribution of Ascorbic Acid in Healthy Human Subjects

 90-DK-0137:

Evaluation of the Gastrinoma in Patients with Zollinger-Ellison Syndrome

Previous 100 Protocols